International Flavors & Fragrances Inc. (IFF)

NYSE: IFF · Real-Time Price · USD
79.09
+0.03 (0.04%)
May 5, 2025, 4:00 PM EDT - Market closed
0.04%
Market Cap 20.23B
Revenue (ttm) 11.48B
Net Income (ttm) 243.00M
Shares Out 255.74M
EPS (ttm) 0.95
PE Ratio 83.32
Forward PE 18.80
Dividend $1.60 (2.02%)
Ex-Dividend Date Jun 20, 2025
Volume 1,143,840
Open 79.16
Previous Close 79.06
Day's Range 78.76 - 79.50
52-Week Range 65.85 - 106.77
Beta 1.23
Analysts Buy
Price Target 94.82 (+19.89%)
Earnings Date May 6, 2025

About IFF

International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and markets food, beverage, health and biosciences, scent, pharma solutions, and complementary adjacent products in the United States, Europe, and internationally. It operates in four segments Nourish, Health & Biosciences, Scent, and Pharma Solutions. The Nourish segment consists of portfolio of natural-based ingredients that includes plant-based specialty food ingredients, such as soy and pea protein with value-added formulations, emulsifiers, and sweeteners... [Read more]

Sector Materials
Founded 1833
Employees 22,400
Stock Exchange NYSE
Ticker Symbol IFF
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 12 analysts, the average rating for IFF stock is "Buy." The 12-month stock price forecast is $94.82, which is an increase of 19.89% from the latest price.

Price Target
$94.82
(19.89% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Roquette Announces a New Organization following the Acquisition of IFF Pharma Solutions

Roquette Announces a New Organization following the Acquisition of IFF Pharma Solutions The company launches two renewed and strengthened Business Groups, and appoints their new leaders Lille, May 5, ...

22 hours ago - GlobeNewsWire

IFF Announces Tender Offers for Certain Outstanding Series of Notes

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) announced today the commencement of tender offers to purchase for cash certain of its outstanding series of notes listed in the tables below (collectively, t...

3 days ago - Business Wire

IFF Declares Dividend for Second Quarter 2025

NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 11, 202...

4 days ago - Business Wire

IFF Completes Divestiture of Pharma Solutions Business Unit

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announced that it has successfully completed the previously announced divestiture of its Pharma Solutions business unit to Roquette. “The completion of...

4 days ago - Business Wire

IFF Pharma Solutions to Showcase Portfolio at Excipient World 2025

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) Pharma Solutions, a global leader in polymer innovations, will showcase its sustainable solutions at Excipient World 2025. The team will feature sustainable ...

7 days ago - Business Wire

IFF Expands Pet Portfolio with Latest Science-driven Solutions

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF), a global powerhouse in bioscience and innovation, today announced a groundbreaking expansion of its pet portfolio. This launch marks a significant leap in I...

7 days ago - Business Wire

IFF Pharma Solutions to Showcase Plant-Based Dietary Supplement Ingredients and Technical Expertise at Vitafoods™ Europe 2025

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) Pharma Solutions is excited to announce its participation at Vitafoods™ Europe 2025, the premier global nutraceutical event. The team will showcase its cutti...

13 days ago - Business Wire

IFF Opens Dubai Creative Center With Perfumery Art Studio

DUBAI, United Arab Emirates--(BUSINESS WIRE)--IFF (NYSE: IFF) announced the inauguration of its Scent Dubai Creative Center, a 2,000-square-meter addition to the company's facility in the Dubai Scienc...

19 days ago - Business Wire

IFF to Release First Quarter 2025 Results on May 6, 2025

NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE:IFF) today announced that it will release its first quarter 2025 earnings results following the market close on Tuesday, May 6, 2025. The management team ...

21 days ago - Business Wire

IFF Opens Mexico Business Hub at Tecnoparque

NEW YORK--(BUSINESS WIRE)--To further strengthen its ability to serve customers with leading innovations, IFF (NYSE: IFF) announced it will combine the majority of its business operations in Mexico at...

25 days ago - Business Wire

IFF Unveils Cutting-Edge Citrus Innovation Center in Florida

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announced the opening of the Citrus Innovation Center in Lakeland, Florida, in partnership with Florida Polytechnic University. This 30,000 square foot...

26 days ago - Business Wire

IFF Pharma Solutions Launches Low Nitrite METHOCEL™ HPMC for Nitrosamine Mitigation

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) Pharma Solutions, a global leader in polymer innovations, today announced the launch of Low Nitrite METHOCEL™ hydroxypropyl methylcellulose (HPMC), a range o...

27 days ago - Business Wire

IFF Introduces Science of Performance: A New Approach to Elevating Scent Design

PARIS--(BUSINESS WIRE)--IFF (NYSE: IFF) unveils its Science of Performance program, a comprehensive, science-driven suite that enhances fragrance creation by increasing efficiency and precision to man...

4 weeks ago - Business Wire

IFF and Kemira Form Joint Venture To Produce Sustainable Biobased Materials at Scale

NEW YORK--(BUSINESS WIRE)--IFF (NYSE:IFF) and Kemira announced the formation of Alpha Bio, a joint venture aimed at commercial-scale production of renewable biobased materials. With an investment of a...

5 weeks ago - Business Wire

IFF Pharma Solutions Brings Next-Gen Excipient Innovations to CPHI Japan 2025

TOKYO--(BUSINESS WIRE)--IFF (NYSE:IFF) Pharma Solutions will showcase its cutting-edge excipient technologies at CPHI Japan 2025. The IFF Pharma Solutions team will highlight its innovations in oral d...

6 weeks ago - Business Wire

IFF Declares Dividend for First Quarter 2025

NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 11, 20...

2 months ago - Business Wire

IFF Announces Expansion of Cedar Rapids, Iowa Ingredients Facility

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today unveiled plans to expand its Cedar Rapids, Iowa facility to capture a larger share of the booming healthy snacks market both in the U.S. and globally. ...

2 months ago - Business Wire

IFF Announces Executive Leadership Team Aligned With New Operating Model

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) announced changes to its executive leadership team, aligned with the Company's external reporting structure. After 21 years of dedicated service to IFF, Simo...

2 months ago - Business Wire

International Flavors & Fragrances Inc. (IFF) Q4 2024 Earnings Call Transcript

International Flavors & Fragrances Inc. (NYSE:IFF) Q4 2024 Earnings Call Transcript February 19, 2025 9:00 AM ET Company Participants Michael Bender - Director, Investor Relations Erik Fyrwald - Chie...

2 months ago - Seeking Alpha

IFF Reports Fourth Quarter and Full Year 2024 Results

NEW YORK--(BUSINESS WIRE)---- $IFF--International Flavors & Fragrances Inc. (NYSE: IFF) reported financial results for the fourth quarter and full year ended December 31, 2024. Full year 2024 Consolid...

2 months ago - Business Wire

IFF to Release Fourth Quarter & Full Year 2024 Results on Feb. 18, 2025; IFF to Present at 2025 CAGNY Conference on Feb. 20, 2025

NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE:IFF) today announced that it will release its fourth quarter and full year 2024 earnings results following the market close on Tuesday, Feb. 18, 2025. The...

3 months ago - Business Wire

IFF Announces Board of Directors Changes

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today unveiled the next phase in the evolution of its Board of Directors, aimed at bolstering the company's long-term strategic vision and driving profitable...

4 months ago - Business Wire

IFF Names Michael DeVeau Chief Financial Officer

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announced that Michael DeVeau—currently Senior Vice President, Corporate Finance and Investor Relations at IFF—has been named the company's Executive V...

5 months ago - Business Wire

Roquette Successfully Completes Inaugural EUR 1.2 billion Bond Offering to Support its Transformative Acquisition of IFF Pharma Solutions

Roquette Successfully Completes Inaugural EUR 1.2 billion Bond Offering to Support its Transformative Acquisition of IFF Pharma Solutions

5 months ago - GlobeNewsWire

Fragrance Maker IFF Positioned For Growth With Revitalized R&D And Attractive Valuation: Analyst

BofA Securities analyst Salvator Tiano upgraded International Flavors & Fragrances, Inc. IFF to Buy from Neutral, lowering the price forecast to $107 from $109.

6 months ago - Benzinga